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Summary: The proline-specific peptidases, aminopeptidase P (EC 3.4.11.9) and dipeptidyl peptidase IV (EC
3.4.14.5), were measured in human tissue homogenates and physiological fluids. All tissues examined contained
measurable aminopeptidase P and dipeptidyl peptidase IV activities. High specific activities for both enzymes
under study were found in benign prostatic hypertrophy. Normal prostate and prostatic adenocarcinoma had
a much lower activity. This difference, however, is not reflected in the serum values of the patients. The most
striking finding is the extremely high activity of dipeptidyl peptidase IV in prostatosomes, prostate-derived
organelles, which occur freely in human seminal plasma, and which are important for enhancement of sperm
forward motility.
Introduction
Peptide bonds containing a proline residue are resist-
ant to a wide variety of peptidases and proteases. The
proline-specific enzymes, aminopeptidase P (EC
3.4.11.9)1) and dipeptidyl peptidase IV (EC
3.4.14.5)1), require a proline at the penultimate posi-
tion of the amino-terminus in the substrate sequence.
Degradation from the N-terminus of naturally occur-
ring peptides containing a proline at this particular
location depends largely on these peptidases. Dipep-
tidyl peptidase IV is an exopeptidase that removes N-
terminal dipeptides from polypeptides with unsubsti-
tuted N-termini. The penultimate residue must be
proline, hydroxyproline, or alanine, the greatest hy-
drolysis rate occurring with proline provided that the
third residue is neither proline nor hydroxyproline.
Aminopeptidase P is a metallo-aminopeptidase that
Enzymes
Aminopeptidase M (EC 3.4.11.2)
Aminopeptidase P (EC 3.4.11.9)
Dipeptidyl peptidase II (EC 3.4.14.2)
Dipeptidyl peptidase IV (EC 3.4.14.5)
Leucyl aminopeptidase (EC 3.4.11.1)
Prolyl aminopeptidase (EC 3.4.11.5)
catalyses specifically the removal of any unsubstituted
N-terminal amino acid, including proline, that is ad-
jacent to a penultimate proline residue. Due to their
specificity towards proline, it has been suggested that
dipeptidyl peptidase IV and aminopeptidase P are
important in the digestion of otherwise resistant die-
tary protein fragments, thereby complementing the
pancreatic peptidases (1, 2), and in the maturation
and degradation of peptide hormones, neuropeptides,
and tachykinins (3 — 6). There is evidence for the
participation of aminopeptidase P and dipeptidyl pep-
tidase IV in the activation and proliferation of T-
lymphocytes (7, 8). Recently, the T-cell surface dipep-
tidyl peptidase IV has been identified as the cluster
differentiation factor CD26 (9).
Cleavage of the proline-containing -chain of fibrin
by dipeptidyl peptidase IV results in an inhibition of
fibrin polymerization (10). The high proline content
in collagen has led to the suggestion of a function for
aminopeptidase P and dipeptidyl peptidase IV in col-
lagen metabolism (11, 12). More recently it has been
shown that dipeptidyl peptidase IV is directly involved
in cellular adhesion to extracellular matrix proteins
by serving as a functional collagen receptor (13).
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Moreover, the determination of dipeptidyl peptidase
IV activity in serum and cerebrospinal fluid has taken
on diagnostic significance (14 — 16). Although the dis-
tribution of aminopeptidase P and dipeptidyl pepti-
dase IV in mammals has been extensively explored
(17 — 20) and although important species differences
have been observed (19, 20), the distribution of ami-
nopeptidase P and dipeptidyl peptidase IV in different
human organs has yet to be systematically studied.
Here, we report the results of a study of the specific
activity of aminopeptidase P and dipeptidyl peptidase
IV in human tissue extracts and body fluids.
Materials and Methods
Body fluids
Sera for reference values were obtained from blood donors,
sperm from healthy donors, and prostatic fluid from vasectom-
ised individuals.
For determination of the enzyme activity in serum from patients
with benign prostatic hypertrophy and with prostatic cancer,
blood samples were taken from patients admitted to the urology
service of the University Hospital of Antwerp for symptoms of
obstruction of the pars prostatica urethrae. Blood samples were
centrifuged at 900 g for 10 min. Serum was aspirated and stored
at —20 °C. After diagnosis of the disease, 41 serum samples of
patients with benign prostatic hypertrophy and 30 samples of
patients with prostatic cancer were retained for the study. Pa-
tients treated by transurethral resection of the prostate were
omitted from the study to avoid falsly elevated levels of enzyme
activity. By means of transrectal echography of the prostate,
CAT-scan of the abdomen and pelvis minor, liver-milt-scan,
RX of the thorax, echography of liver and abdomen, and bone
scan, the patients with prostatic carcinoma were classified ac-
cording to the American urological system in classes Al to D2.
Tissues
The tissues were obtained by open surgery. Except when spe-
cifically noted, only parts of tissue not involved in the disease
process were used. Prostatectomy was performed in patients
with prostatic carcinoma and benign prostatic hypertrophy.
Normal prostate tissue was acquired from patients with bladder
cancer. All tissues were washed with cold saline and stored as
soon as possible in liquid nitrogen, brought to the laboratory,
and kept frozen at — 80 °C. Tissue homogenates were made by
grinding the tissues in a Potter-Elvejhem glass homogenizer
fitted with a Teflon pestle, either with one drop of Nonidet P40
(LKB, Bromma, Sweden) per 200 mg tissue, or by the method
of Lazo & Quinn (22), using a 30 mmol/1 solution of octyl- -
Z)-glucopyranoside (Calbiochem-Behring, La Jolla, LA, USA).
After centrifugation at 50 000 # for 30 minutes at 4°C, the
supernatant was stored at —80 °C until determination of ami-
nopeptidase P and dipeptidyl peptidase IV activity and protein
concentration.
Different ial centr ifugation of seminal plasma
Seminal plasma was centrifuged at 900 g for 10 min in a MSB
Hi-spin 21 centrifuge (MSB Scientific Instruments, Sussex,
UK), resulting in a pellet containing the spermatozoa and a
supernatant. The supernatant was centrifuged at 105000g for
120 min in a Beckman ultracentrifuge model L350 (Beckman
Instruments, M nchen, Germany), to precipitate the prosta-
tosomes. The supernatant contains the seminal fluid. The sper-
matozoan and prostatosome pellets were separately resus-
pended in 20 mmol/1 Tris, pH 7.4, 1% Triton X-100, and
centrifuged at 40000 g for 20 min.
Protein measurement
Protein concentrations were determined by the bicinchoninic
acid-detection reagent (Pierce Chemical Company, Rockford,
IL, USA). Bovine serum albumin was used as the standard.
Enzyme assays
Aminopeptidase P activity was measured using the intramole-
cularly quenched fluorogenic substrate Lys(2,4 dinitrophenyl)-
Pro-Pro-NH-CH2-CH2-NH-2-aminobenzoyl · 2HC1 (17). The
samples are incubated at 40 °C with 0.5 mmol/1 substrate in 0.2
mol/1 Tris-HCl, pH 8.0, 10 mmol/1 trisodium citrate and 2.6
mmol/1 MnSO4. The reaction is stopped by the addition of 0.2
mol/1 Tris-HCl, pH 8.0, 50 mmol/1 EDTA, 1 mmol/1 dithio-
threitol. Fluorescence measurements were performed at exci-
tation wavelength 320 nm and emission wavelength 410 nm.
Dipeptidyl peptidase IV activity was determined by a fluoro-
metric and a colorimetric method. The manual fluorometric
method has been described elsewhere (23). Briefly, the enzyme
is incubated at 37 °C with 1.4 mmol/1 Gly-Pro-4-methoxy-2-
naphthylamide in 50 mmol/1 Tris-HCl, pH 8.3. The reaction is
stopped by the addition of 0.1 mol/1 citrate buffer pH 4.0, after
which the fluorescence of the formed 4-methoxy-2-naphthylam-
ine is measured at excitation wavelength 340 nm and at an
emission wavelength of 425 nm. When necessary, tissue extracts
were diluted before measurement of the enzyme activities to
keep product formation within the limits of method linearity.
Possible interference in the dipeptidyl peptidase IV assay by
successive cleavage by aminopeptidases (all metalloproteases)
of the substrate Gly-Pro-4-methoxy- -napthylamide was con-
trolled by measurement of the residual activity after inhibition
of dipeptidyl peptidase IV by addition of diisopropyl fluoro-
phosphate to the tissue extracts to a final concentration of 1.5
mmol/1. To check for the presence of substances in the tissue
extracts exerting a quenching effect in the fluorometric assay
(24), the colorimetric method described by Nagatsu et al. (25),
which uses the chromogenic substrate glycyl-L-proline-/?-ni-
troanilide tosylate, was adapted for direct continuous measure-
ment on the centrifugal analyser Cobas Bio (Roche Diagnostics,
Germany). The within- and between-run precisions of the assay
were both less than 2% CV (n = 10). One unit of enzyme
catalytic activity was defined as the amount of enzyme catalys-
ing the formation of 1 μηιοί assay product per minute under
assay conditions.
Results
The specific activities of aminopeptidase Ρ and dipep-
tidyl peptidase IV, expressed in U/g protein are pre-
sented in figures 1 and 2.
Dipeptidyl peptidase IV activities were determined
fluorometrically and colorimetrically. Both methods
proved to be useful for the determination of dipeptidyl
peptidase IV in tissue extracts. The specific activities
determined by either method correlated well for each
extract, thus excluding the possibility that the fluo-
rescence measurements are subjects to interference by
quenching substances in the tissue extracts. Dipeptidyl
peptidase II (EC 3.4.14.2)1) also attacks Gly-Pro-
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 6
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Fig. \. Distribution of dipeptidyl peptidase IV in human tissue extracts and body fluids. The vertical bars indicate the range in
specific activity obtained for the number (n) of tissues examined. Note the extremely high values in prostasomes (range
295 — 1813 U/g protein) and in prostates from patients suffering from benign prostatic hypertrophy (range 98 — 315 U/g
protein).
Fig. 2. Distribution of aminopeptidase P in human tissue extracts and body fluids. The vertical bars indicate the range in specific
activity obtained for the number (n) of tissues examined.
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arylamides with direct release of a fluorescent product
(26). Interference by this peptidase, which has a pH
optimum below pH 6, was excluded by working at a
high pH value (pH 8.3). Aminopeptidase P can re-
move the N-terminal Gly from the substrate, resulting
in Pro-arylamide. The Pro can be removed by leucyl-
aminopeptidase (EC 3.4.11.1)2), which has recently
been shown to be identical to prolyl aminopeptidase
(EC 3.4.11.5)1) (27, 28), and aminopeptidase M (EC
3.4.11.2)1), resulting in the formation of the fluores-
cent product. As a control for the successive cleavage
of the substrate by these metallopeptidases, the di-
peptidyl peptidase IV activity was inhibited by 1.5
mmol/1 diisopropyl fluorophosphate and the residual
activity was measured following the standard assay
procedure (23). In all measured extracts, the residual
activity remained below 5% except for the gall blad-
der (17%), the sigmoid carcinoma (11%), the colon
transversum (10%) and for the ovarium extract (7%).
Because of the significant differences in the specific
activities of the proline-specific enzymes in tissue from
benign prostatic hypertrophy and prostatic cancer, we
checked to see whether this difference is reflected in
the enzyme serum values of the patients. The results
are listed in table 1. No significant difference in di-
peptidyl peptidase IV and aminopeptidase P serum
values between patients suffering from benign pros-
tatic hypertrophy or prostatic carcinoma and normal
individuals were detected. Only the serum aminopep-
tidase P activity is significantly correlated with the
Tab. 1. Aminopeptidase P and dipeptidyl peptidase IV activi-
ties in serum of healthy individuals and of patients with
















































mean, range, and SD are expressed in U/l
tumour stage (p — 0.03, Spearman rank correlation
test) in untreated patients. However, when the ami-
nopeptidase P serum value of a mixed group of treated
and untreated patients with prostatic carcinoma was
compared with the development of the tumour, no
correlation could be demonstrated (p = 0.71, Spear-
man rank correlation rest).
Discussion
Our studies on extracted tissues show that all organs
examined contain dipeptidyl peptidase IV as well as
aminopeptidase P activity, but the distribution of the
enzymes differs significantly. For both enzymes, by
far the highest specific activity was found in prostatic
tissue extracts from patients suffering from benign
prostatic hypertrophy. The striking difference in spe-
cific activities of both peptidases between patients
suffering from benign prostatic hypertrophy and pros-
tatic cancer is not reflected in the serum values of the
patients. Although the serum aminopeptidase P activ-
ity of untreated patients with prostatic cancer is sig-
nificantly correlated with the tumour stage, this serum
value is in our opinion of no clinical use, since no
correlation was found in a mixed group of treated
and untreated patients. The most striking finding is
the extremely high specific activity of dipeptidyl pep-
tidase IV in prostatosomes, prostate-derived organ-
elles that occur freely in human seminal fluid. Human
testicular tissue contains very low dipeptidyl peptidase
IV activity. These results suggest that dipeptidyl pep-
tidase IV from seminal plasma is at least partly syn-
thesised in human prostate and secreted into the pros-
tatic duct, thus contributing to the activity in seminal
plasma. The physiological function of dipeptidyl pep-
tidase IV in human seminal plasma is still unclear.
Substance P, which regulates the activation of acetyl-
choline, can be cleaved by dipeptidyl peptidase IV.
The activity of dipeptidyl peptidase IV can thus in-
directly influence the role of acetylcholine in the reg-
ulation of sperm motility (29). Because of the high
specific activity of dipeptidyl peptidase IV in human
prostatosomes, the involvement of prostatosomes in
sperm forward motility (30) may be at least partly
due to its dipeptidyl peptidase IV activity. As could
be predicted from previous studies (31, 32), high ami-,
nopeptidase P and dipeptidyl peptidase IV activities
were found in human kidney and small intestine.
Much attention has already been paid to, and evi-
dence given for, the role of both proline-specific en-
zymes in peptide metabolism and transport in the
brush border of the kidney and the small intestine
(33 — 35). In contrast to the distribution of aminopep-
tidase P in rat organs, where the specific activity is
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 6
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by far the highest in the lung and ovary, we found
relatively low activities for aminopeptidase P as well
as for dipeptidyl peptidase IV in the human lung,
relative to the other organs. The activity of amino-
peptidase P and dipeptidyl peptidase IV in human
lung is important for evaluating the significance for
human physiology of the studies by Baker et al. (36).
These authors showed that the combined action of
aminopeptidase P and dipeptidyl peptidase IV pro-
duces the major metabolite formed during inactiva-
tion of circulating bradykinin in perfused rat lung.
Human aminopeptidase P, however, is present in
blood cells in a higher specific activity than in human
lung (7, 37, 38). Care must therefore be taken not to
apply findings for rat bradykinin metabolism directly
to the human physiology, since other organs and
especially blood cells may contribute more to brady-
kinin metabolism in humans than in rats. However,
since human aminopeptidase P has a high affinity for
bradykinin and since none of the angiotensins are
substrates for aminopeptidase P, the development of
specific inhibitors for aminopeptidase P may be useful
for the highly selective control of bradykinin metab-
olism.
It is clear that the distribution of both enzymes varies
considerably between species (19, 21). Therefore, the
present study adds to the present knowledge of the
possible functions of aminopeptidase P and dipeptidyl
peptidase IV in human tissues. Since all activities were
measured in total tissue extracts, one has to be cau-
tious in interpreting attempts to define a general phys-
iological role for a given enzyme. More detailed lo-
calization of the enzyme activities in the different
tissues are required to be able to correlate the obser-
vations with the availability of possible biologically
active substrates. The extremely high activity of di-
peptidyl peptidase IV in human prostatosomes, how-
ever, is a very interesting observation, which deserves
further investigation as part of the search for mech-
anisms controlling male fertility.
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